Suppr超能文献

血管内血栓切除术治疗前循环大血管缺血性卒中:一项更新的荟萃分析。

Endovascular thrombectomy after anterior circulation large vessel ischemic stroke: an updated meta-analysis.

机构信息

College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.

King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.

出版信息

Syst Rev. 2024 Oct 12;13(1):255. doi: 10.1186/s13643-024-02670-6.

Abstract

BACKGROUND

Endovascular thrombectomy (EVT) has emerged as the established standard of care for the treatment of anterior circulation large-vessel occlusion (LVO). However, its benefits remain unclear in specific patient populations. Herein, we present an updated systematic review and meta-analysis aimed at thoroughly assessing the effectiveness and safety of combining EVT with medical treatment (MT) compared with MT alone.

METHODS

This systematic review was performed in accordance with the PRISMA guideline. The MEDLINE, Embase, and Cochrane databases were systematically searched to identify relevant articles published until December 30, 2023. The inclusion criteria restricted articles to randomized clinical trials (RCTs). We pooled odds ratios (OR) and their respective 95% confidence intervals (CIs).

RESULTS

Fifteen RCTs involving 3897 patients were included in the study. EVT plus MT was associated with a significant reduction in disability at 90 days (OR = 1.91, [1.61-2.26]), improved functional independence (modified Rankin Scale [mRS] 0-2) (OR = 2.19 [1.81-2.64]), excellent functional outcomes (mRS 0-1) (OR = 2.37, [1.45-3.87]), improved independent ambulation (mRS 0-3) (OR = 2.17, [1.75-2.69]), and higher rates of partial/complete recanalization (OR = 2.18, [1.66-2.87] compared with EVT. Efficacy outcomes for both large and small infarct cores were statistically favorable following EVT. Safety outcomes showed comparable rates, except for intracerebral and subarachnoid hemorrhage, which favored MT alone.

CONCLUSION

This meta-analysis supports the use of EVT plus MT as the standard of care for acute ischemic stroke patients with LVO of any infarct core size, as it offers substantial improvements in functional outcomes and recanalization. Safety considerations, particularly the risk of hemorrhage, warrant careful patient selection. These findings provide valuable insights for optimizing stroke management protocols and enhancing patient outcomes.

摘要

背景

血管内血栓切除术 (EVT) 已成为治疗前循环大血管闭塞 (LVO) 的既定标准治疗方法。然而,其在特定患者人群中的益处仍不明确。在此,我们进行了一项更新的系统评价和荟萃分析,旨在全面评估 EVT 联合药物治疗 (MT) 与单独 MT 相比的有效性和安全性。

方法

本系统评价按照 PRISMA 指南进行。系统检索了 MEDLINE、Embase 和 Cochrane 数据库,以确定截至 2023 年 12 月 30 日发表的相关文章。纳入标准将文章限定为随机临床试验 (RCT)。我们汇总了比值比 (OR) 及其各自的 95%置信区间 (CI)。

结果

共有 15 项 RCT 纳入了 3897 名患者。EVT 联合 MT 可显著降低 90 天残疾率 (OR=1.91,[1.61-2.26]),提高功能独立性 (改良 Rankin 量表 [mRS] 0-2) (OR=2.19,[1.81-2.64]),提高良好功能结局 (mRS 0-1) (OR=2.37,[1.45-3.87]),提高独立行走能力 (mRS 0-3) (OR=2.17,[1.75-2.69]),以及更高的部分/完全再通率 (OR=2.18,[1.66-2.87])。EVT 对大梗死核心和小梗死核心的疗效结果均具有统计学优势。安全性结果显示,除颅内出血和蛛网膜下腔出血外,两组的发生率相当,而后者更有利于 MT 单独治疗。

结论

本荟萃分析支持将 EVT 联合 MT 作为急性缺血性脑卒中伴任何梗死核心大小 LVO 患者的标准治疗方法,因为它可显著改善功能结局和再通率。安全性考虑因素,特别是出血风险,需要仔细选择患者。这些发现为优化脑卒中管理方案和提高患者结局提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4edb/11475204/cda7838fc1c5/13643_2024_2670_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验